• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原发性硬化性胆管炎小胆管型自然病程:病例系列并文献复习。

Natural history of small duct primary sclerosing cholangitis: a case series with review of the literature.

机构信息

Department of Gastroenterology, University of Texas Medical Branch, Galveston, TX, USA.

出版信息

Hepatol Int. 2011 Sep;5(3):808-13. doi: 10.1007/s12072-011-9260-4. Epub 2011 Mar 11.

DOI:10.1007/s12072-011-9260-4
PMID:21484124
Abstract

BACKGROUND AND AIMS

Information about the natural history of small duct primary sclerosing cholangitis (SDPSC) remains scant despite literature suggesting that it constitutes 6-16% of all cases of primary sclerosing cholangitis (PSC). We combined clinical data on SDPSC cases from two tertiary care institutions with liver transplantation programs with the aim of studying the natural history of SDPSC.

METHODS

Medical records of 25 individuals with SDPSC were reviewed. Diagnosis of SDPSC was based on liver biopsy findings consistent with PSC, a normal cholangiogram, and elimination of known causes of secondary sclerosing cholangitis. Demographic information, symptoms, past medical history, laboratory values, and histologic data were evaluated. Our primary outcome measure was liver transplantation or death. Secondary outcome measures included evidence of end-stage liver disease, development of cholangiocarcinoma, and/or the development of classic PSC on a repeat cholangiogram.

RESULTS

Data on 25 individuals (13 males, 12 females; mean age 40 ± 15 years) diagnosed with SDPSC were analyzed. Upon presentation, 11 patients had symptoms including abdominal pain, fatigue, and pruritus. Inflammatory bowel disease was present in 14 patients (56%) at diagnosis. On initial liver biopsy, 60% had early-stage disease (I or II) and none had cirrhosis. On follow-up (1-168 months, median 17 months), malignancy or progression to classic large duct PSC was not noted. Two (8%) patients had evidence of varices and one of the two also developed ascites; one of these patients underwent liver transplantation and the other one died due to sepsis.

CONCLUSIONS

SDPSC, a mild disease at presentation typically runs a benign course and likely is not an early stage of classic PSC. Further studies with a control group of classic PSC and longer follow-up are needed to study the natural history of SDPSC.

摘要

背景与目的

尽管文献表明小胆管原发性硬化性胆管炎(SDPSC)占原发性硬化性胆管炎(PSC)病例的 6-16%,但有关其自然病史的信息仍然很少。我们将两家有肝移植项目的三级保健机构的 SDPSC 病例的临床数据结合起来,旨在研究 SDPSC 的自然病史。

方法

对 25 例 SDPSC 患者的病历进行了回顾。SDPSC 的诊断依据是肝活检符合 PSC 的表现、胆管造影正常以及排除了继发性硬化性胆管炎的已知病因。评估了人口统计学信息、症状、既往病史、实验室值和组织学数据。我们的主要结局测量指标是肝移植或死亡。次要结局测量指标包括终末期肝病的证据、胆管癌的发展和/或重复胆管造影时经典 PSC 的发展。

结果

对 25 例(13 名男性,12 名女性;平均年龄 40±15 岁)被诊断为 SDPSC 的患者的数据进行了分析。在就诊时,11 例患者有腹痛、疲劳和瘙痒等症状。14 例患者(56%)在诊断时存在炎症性肠病。在初始肝活检时,60%的患者为早期疾病(I 期或 II 期),无一例患者有肝硬化。在随访(1-168 个月,中位数 17 个月)期间,未发现恶性肿瘤或进展为经典大胆管 PSC。2 例(8%)患者有静脉曲张的证据,其中 1 例患者也出现腹水;这 2 例患者中有 1 例接受了肝移植,另 1 例因败血症死亡。

结论

SDPSC 是一种在发病时较轻的疾病,通常表现为良性病程,可能不是经典 PSC 的早期阶段。需要对经典 PSC 进行对照研究和更长时间的随访,以研究 SDPSC 的自然病史。

相似文献

1
Natural history of small duct primary sclerosing cholangitis: a case series with review of the literature.原发性硬化性胆管炎小胆管型自然病程:病例系列并文献复习。
Hepatol Int. 2011 Sep;5(3):808-13. doi: 10.1007/s12072-011-9260-4. Epub 2011 Mar 11.
2
Small duct primary sclerosing cholangitis: A discrete variant or a bridge to large duct disease, a practical review.小胆管原发性硬化性胆管炎:一种独立的变异型还是通向大胆管疾病的桥梁,一项实用性综述
World J Hepatol. 2022 Mar 27;14(3):495-503. doi: 10.4254/wjh.v14.i3.495.
3
Clinical features and MRI progression of small duct primary sclerosing cholangitis (PSC).小胆管原发性硬化性胆管炎(PSC)的临床特征和 MRI 进展。
Eur J Radiol. 2020 Aug;129:109101. doi: 10.1016/j.ejrad.2020.109101. Epub 2020 Jun 1.
4
Patients with small duct primary sclerosing cholangitis have a favourable long term prognosis.小胆管原发性硬化性胆管炎患者的长期预后良好。
Gut. 2002 Nov;51(5):731-5. doi: 10.1136/gut.51.5.731.
5
Small-duct primary sclerosing cholangitis. A single-center seven-year experience.小胆管原发性硬化性胆管炎。一项单中心七年经验总结。
Dig Dis Sci. 2005 Feb;50(2):324-6. doi: 10.1007/s10620-005-1604-2.
6
Small-duct primary sclerosing cholangitis: a long-term follow-up study.小胆管原发性硬化性胆管炎:一项长期随访研究。
Hepatology. 2002 Jun;35(6):1494-500. doi: 10.1053/jhep.2002.33202.
7
The natural history of small-duct primary sclerosing cholangitis.小胆管原发性硬化性胆管炎的自然病史。
Gastroenterology. 2008 Apr;134(4):975-80. doi: 10.1053/j.gastro.2008.01.042. Epub 2008 Jan 17.
8
Small-duct primary sclerosing cholangitis.小胆管原发性硬化性胆管炎
Curr Gastroenterol Rep. 2009 Feb;11(1):37-41. doi: 10.1007/s11894-009-0006-6.
9
Orthotopic liver transplantation for primary sclerosing cholangitis. A 12-year single center experience.原发性硬化性胆管炎的原位肝移植:单中心12年经验
Ann Surg. 1997 May;225(5):472-81; discussion 481-3. doi: 10.1097/00000658-199705000-00004.
10
Natural history and outcome in 32 Swedish patients with small duct primary sclerosing cholangitis (PSC).32例瑞典小胆管原发性硬化性胆管炎(PSC)患者的自然病史及预后
J Hepatol. 2002 May;36(5):586-9. doi: 10.1016/s0168-8278(02)00036-3.

引用本文的文献

1
The Diagnostic Value of FibroTest and Hepascore as Non-Invasive Markers of Liver Fibrosis in Primary Sclerosing Cholangitis (PSC).FibroTest和Hepascore作为原发性硬化性胆管炎(PSC)肝纤维化无创标志物的诊断价值
J Clin Med. 2023 Dec 7;12(24):7552. doi: 10.3390/jcm12247552.
2
Small duct primary sclerosing cholangitis: A discrete variant or a bridge to large duct disease, a practical review.小胆管原发性硬化性胆管炎:一种独立的变异型还是通向大胆管疾病的桥梁,一项实用性综述
World J Hepatol. 2022 Mar 27;14(3):495-503. doi: 10.4254/wjh.v14.i3.495.
3
Review of incidence and outcomes of treatment of cholangiocarcinoma in patients with primary sclerosing cholangitis.

本文引用的文献

1
Diagnosis and management of primary sclerosing cholangitis.原发性硬化性胆管炎的诊断与管理
Hepatology. 2010 Feb;51(2):660-78. doi: 10.1002/hep.23294.
2
The natural history of small-duct primary sclerosing cholangitis.小胆管原发性硬化性胆管炎的自然病史。
Gastroenterology. 2008 Apr;134(4):975-80. doi: 10.1053/j.gastro.2008.01.042. Epub 2008 Jan 17.
3
The burden of large and small duct primary sclerosing cholangitis in adults and children: a population-based analysis.成人和儿童大小胆管原发性硬化性胆管炎的负担:基于人群的分析。
原发性硬化性胆管炎患者胆管癌的发病率及治疗结局综述。
World J Gastrointest Oncol. 2021 Oct 15;13(10):1336-1366. doi: 10.4251/wjgo.v13.i10.1336.
4
Cholangiocarcinoma in Patients with Primary Sclerosing Cholangitis (PSC): a Comprehensive Review.原发性硬化性胆管炎(PSC)患者的胆管癌:全面综述。
Clin Rev Allergy Immunol. 2020 Feb;58(1):134-149. doi: 10.1007/s12016-019-08764-7.
5
Vigilancia del colangiocarcinoma en pacientes con colangitis esclerosante primaria: ¿es efectiva y está justificada?原发性硬化性胆管炎患者胆管癌的监测:是否有效且合理?
Clin Liver Dis (Hoboken). 2016 Nov 10;8(Suppl 1):S20-S24. doi: 10.1002/cld.602. eCollection 2016 Nov.
6
Update in the Care and Management of Patients with Primary Sclerosing Cholangitis.原发性硬化性胆管炎患者护理与管理的最新进展
Curr Gastroenterol Rep. 2018 Jun 9;20(7):29. doi: 10.1007/s11894-018-0635-8.
7
Patient Age, Sex, and Inflammatory Bowel Disease Phenotype Associate With Course of Primary Sclerosing Cholangitis.患者年龄、性别及炎症性肠病表型与原发性硬化性胆管炎病程相关。
Gastroenterology. 2017 Jun;152(8):1975-1984.e8. doi: 10.1053/j.gastro.2017.02.038. Epub 2017 Mar 6.
8
Surveillance for Cholangiocarcinoma in Patients with Primary Sclerosing Cholangitis: Effective and Justified?原发性硬化性胆管炎患者胆管癌的监测:有效且合理吗?
Clin Liver Dis (Hoboken). 2016 Aug;8(2):43-47. doi: 10.1002/cld.567. Epub 2016 Aug 29.
9
Cholangiocarcinoma Secondary to Primary Sclerosing Cholangitis in Explanted Livers: A Single-Center Study in the South of Iran.移植肝中继发于原发性硬化性胆管炎的胆管癌:伊朗南部的一项单中心研究
Hepat Mon. 2015 Dec 27;15(12):e33626. doi: 10.5812/hepatmon.33626. eCollection 2015 Dec.
10
Current Concepts in Primary Biliary Cirrhosis and Primary Sclerosing Cholangitis.原发性胆汁性肝硬化和原发性硬化性胆管炎的当前概念
Clin Transl Gastroenterol. 2015 Aug 27;6(8):e109. doi: 10.1038/ctg.2015.33.
Am J Gastroenterol. 2007 May;102(5):1042-9. doi: 10.1111/j.1572-0241.2007.01103.x. Epub 2007 Feb 21.
4
Primary sclerosing cholangitis: summary of a workshop.原发性硬化性胆管炎:研讨会总结
Hepatology. 2006 Sep;44(3):746-64. doi: 10.1002/hep.21337.
5
Primary sclerosing cholangitis: epidemiology, natural history, and prognosis.原发性硬化性胆管炎:流行病学、自然史及预后
Semin Liver Dis. 2006 Feb;26(1):22-30. doi: 10.1055/s-2006-933560.
6
Small-duct primary sclerosing cholangitis. A single-center seven-year experience.小胆管原发性硬化性胆管炎。一项单中心七年经验总结。
Dig Dis Sci. 2005 Feb;50(2):324-6. doi: 10.1007/s10620-005-1604-2.
7
Incidence and risk factors for cholangiocarcinoma in primary sclerosing cholangitis.原发性硬化性胆管炎中胆管癌的发病率及危险因素
Am J Gastroenterol. 2004 Mar;99(3):523-6. doi: 10.1111/j.1572-0241.2004.04067.x.
8
Incidence, clinical spectrum, and outcomes of primary sclerosing cholangitis in a United States community.美国一个社区中原发性硬化性胆管炎的发病率、临床谱及预后
Gastroenterology. 2003 Nov;125(5):1364-9. doi: 10.1016/j.gastro.2003.07.011.
9
Patients with small duct primary sclerosing cholangitis have a favourable long term prognosis.小胆管原发性硬化性胆管炎患者的长期预后良好。
Gut. 2002 Nov;51(5):731-5. doi: 10.1136/gut.51.5.731.
10
Small-duct primary sclerosing cholangitis: a long-term follow-up study.小胆管原发性硬化性胆管炎:一项长期随访研究。
Hepatology. 2002 Jun;35(6):1494-500. doi: 10.1053/jhep.2002.33202.